Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Susan L. Kelley currently holds 40,000 shares of Deciphera Pharmaceuticals, Inc. (N/A), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Susan L. Kelley has been a net buyer of N/A stock. They have purchased $60.0K and sold $0 worth of shares.
Susan L. Kelley's most recent insider trade was on Jun 11, 2024, when they sold 3,269 shares at $0.00 per share.
Susan L. Kelley serves as Executive at Deciphera Pharmaceuticals, Inc. (N/A). They have executed 9 insider transactions totaling $60.0K over their tenure at the company.
Susan L. Kelley holds the position of Executive at Deciphera Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Susan L. Kelley has shown a buying trading pattern, with $60.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Susan L. Kelley was on Jan 16, 2020, when they sold $1.0M worth of ARQL shares. This transaction involved 50,000 shares at $20.00 per share.
Susan L. Kelley currently owns 40,000 shares of Deciphera Pharmaceuticals, Inc. (N/A), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Susan L. Kelley's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Susan L. Kelley has 9 Form 4 filings on record as an insider at Deciphera Pharmaceuticals, Inc..
Set alerts for Susan L. Kelley and 40,000+ other insiders.